@alkermes.com
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Alkermes is a biopharmaceutical company based in United States with headquarters in Dublin, Ireland. The company was founded in 1987 and initially focused on developing drug delivery technologies. Over the years, it has expanded its focus to include the development of innovative medicines for the treatment of central nervous system (CNS) disorders.
Alkermes' headquarters is located in Dublin, Ireland. The company operates manufacturing and research facilities in the United States, as well as in Athlone, Ireland. These facilities enable the company to develop and produce its range of products for distribution worldwide.
Alkermes offers a variety of products and services. Its main products include medications for the treatment of schizophrenia, bipolar disorder, and addiction. These include medications such as Aristada, a long-acting injectable for the treatment of schizophrenia, and Vivitrol, a once-monthly injection for the treatment of alcohol and opioid dependence.
On a global scale, Alkermes operates through various subsidiaries, including Alkermes Pharma Ireland Limited and Alkermes Holdings Ireland Limited. The company has also formed strategic partnerships and collaborations with other pharmaceutical companies to enhance its product development capabilities. For example, it has partnered with Johnson & Johnson to develop a long-acting injectable treatment for schizophrenia.
Alkermes has solidified its market position through its innovative product portfolio. Its products have gained recognition for their effectiveness in treating CNS disorders, positioning the company as a leader in this therapeutic area. Moreover, the company has witnessed steady global sales growth and has maintained a competitive edge over its rivals.
In terms of major events and achievements, Alkermes has successfully commercialized several innovative products, expanding its reach in the global pharmaceutical market. Additionally, the company has made strategic acquisitions and license agreements to strengthen its product pipeline and expand its market presence. As of the latest information available, Alkermes continues to focus on developing new treatment options for CNS disorders.
The company is committed to improving the lives of patients through scientific research, innovation, and strategic partnerships. In conclusion, Alkermes is a prominent biopharmaceutical company specializing in the development of treatments for CNS disorders. With headquarters in Dublin, Ireland, the company operates globally and has established a strong market position through its innovative product portfolio.
Through strategic partnerships and acquisitions, Alkermes continues to advance its research and development efforts, with a commitment to improving the lives of patients worldwide
Company Type
Public Company
Company Size
1001-5000
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories